Novel antibody for the treatment of transthyretin amyloidosis

Journal of Biological Chemistry

Volumn 291, Issue 48, 2016, Pages 25096-25105

  Hosoi, Akihiko ^a   Su, Yu ^b   Torikai, Masaharu ^a   Jono, Hirofumi ^b,d   Ishikawa, Daisuke ^a   Soejima, Kenji ^a   Higuchi, Hirofumi ^a   Guo, Jianying ^b   Ueda, Mitsuharu ^b   Suenaga, Genki ^b   Motokawa, Hiroaki ^b   Ikeda, Tokunori ^c   Senju, Satoru ^c   Nakashima, Toshihiro ^a   Ando, Yukio ^b  

^a Kaketsuken   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; DISEASES; MONOCLONAL ANTIBODIES;

AMYLOID FORMATION; CONFORMATIONAL CHANGE; EFFECTIVE THERAPY; FAMILIAL AMYLOIDOTIC POLYNEUROPATHY; GASTROINTESTINAL TRACT; INCURABLE DISEASE; SYSTEMIC AMYLOIDOSIS; THERAPEUTIC ANTIBODIES;

ANTIBODIES;

EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY T24; PREALBUMIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL AMYLOID POLYNEUROPATHY; GASTROINTESTINAL TRACT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOLECULAR RECOGNITION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; WESTERN BLOTTING; AMYLOID NEUROPATHIES, FAMILIAL; ANIMAL; DRUG EFFECTS; FEMALE; IMMUNOLOGY; MALE; MOUSE; PATHOLOGY;

AMYLOID NEUROPATHIES, FAMILIAL; ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; FEMALE; HUMANS; MACROPHAGES; MALE; MICE; PHAGOCYTOSIS; PREALBUMIN; RATS;

EID: 84998546829     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M116.738138     Document Type: Article

References (33)

1. Glenner, G. G. (1980) Amyloid deposits and amyloidosis: the β-fibrilloses (second of two parts). N. Engl. J. Med. 302, 1333-1343
2. Araki, S., and Ando, Y. (2010) Transthyretin-related familial amyloidotic polyneuropath-Progress in Kumamoto, Japan (1967-2010). Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 86, 694-706
3. Ueda, M., and Ando, Y. (2014) Recent advances in transthyretin amyloidosis therapy. Transl. Neurodegener. 3, 19
4. Ando, Y., Nakamura, M., and Araki, S. (2005) Transthyretin-related familial amyloidotic polyneuropathy. Arch. Neurol. 62, 1057-1062
5. Hou, X., Aguilar, M. I., and Small, D. H. (2007) Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration. FEBS J. 274, 1637-1650
6. Jiang, X., Smith, C. S., Petrassi, H. M., Hammarström, P., White, J. T., Sacchettini, J. C., and Kelly, J. W. (2001) An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. Biochemistry 40, 11442-11452
7. Foss, T. R., Kelker, M. S., Wiseman, R. L., Wilson, I. A., and Kelly, J. W. (2005) Kinetic stabilization of the native state by protein engineering: implications for inhibition of transthyretin amyloidogenesis. J. Mol. Biol. 347, 841-854
8. Hurshman, A. R., White, J. T., Powers, E. T., and Kelly, J. W. (2004) Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry 43, 7365-7381
9. Ando, Y., Ando, E., Tanaka, Y., Yamashita, T., Tashima, K., Suga, M., Uchino, M., Negi, A., and Ando, M. (1996) De novo amyloid synthesis in ocular tissue in familial amyloidotic polyneuropathy after liver transplantation. Transplantation 62, 1037-1038
10. Falk, R. H., and Dubrey, S. W. (2010) Amyloid heart disease. Prog. Cardiovasc. Dis. 52, 347-361
11. Said, G., Grippon, S., and Kirkpatrick, P. (2012) Tafamidis. Nat. Rev. Drug Discov. 11, 185-186
12. Coelho, T., Adams, D., Silva, A., Lozeron, P., Hawkins, P. N., Mant, T., Perez, J., Chiesa, J., Warrington, S., Tranter, E., Munisamy, M., Falzone, R., Harrop, J., Cehelsky, J., Bettencourt, B. R., et al. (2013) Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N. Engl. J. Med. 369, 819-829
13. Goldsteins, G., Persson, H., Andersson, K., Olofsson, A., Dacklin, I., Edvinsson, A., Saraiva, M. J., and Lundgren, E. (1999) Exposure of cryptic epitopes on transthyretin only in amyloid and in amyloidogenic mutants. Proc. Natl. Acad. Sci. U.S.A. 96, 3108-3113
14. Kohno, K., Palha, J. A., Miyakawa, K., Saraiva, M. J., Ito, S., Mabuchi, T., Blaner, W. S., Iijima, H., Tsukahara, S., Episkopou, V., Gottesman, M. E., Shimada, K., Takahashi, K., Yamamura, K., and Maeda, S. (1997) Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy. Am. J. Pathol. 150, 1497-1508
15. Terazaki, H., Ando, Y., Fernandes, R., Yamamura, K., Maeda, S., and Saraiva, M. J. (2006) Immunization in familial amyloidotic polyneuropathy: counteracting deposition by immunization with a Y78F TTR mutant. Lab. Invest. 86, 23-31
16. Gustavsson, A., Engström, U., and Westermark, P. (1994) Mechanisms of transthyretin amyloidogenesis. Antigenic mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localizations. Am. J. Pathol. 144, 1301-1311
17. Eneqvist, T., Olofsson, A., Ando, Y., Miyakawa, T., Katsuragi, S., Jass, J., Lundgren, E., and Sauer-Eriksson, A. E. (2002) Disulfide-bond formation in the transthyretin mutant Y114C prevents amyloid fibril formation in vivo and in vitro. Biochemistry 41, 13143-13151
18. Bergström, J., Engström, U., Yamashita, T., Ando, Y., and Westermark, P. (2006) Surface exposed epitopes and structural heterogeneity of in vivo formed transthyretin amyloid fibrils. Biochem. Biophys. Res. Commun. 348, 532-539
19. Ueda, M., Ando, Y., Hakamata, Y., Nakamura, M., Yamashita, T., Obayashi, K., Himeno, S., Inoue, S., Sato, Y., Kaneko, T., Takamune, N., Misumi, S., Shoji, S., Uchino, M., and Kobayashi, E. (2007) A transgenic rat with the human ATTR V30M: a novel tool for analyses of ATTR metabolisms. Biochem. Biophys. Res. Commun. 352, 299-304
20. Su, Y., Jono, H., Torikai, M., Hosoi, A., Soejima, K., Guo, J., Tasaki, M., Misumi, Y., Ueda, M., Shinriki, S., Shono, M., Obayashi, K., Nakashima, T., Sugawara, K., and Ando, Y. (2012) Antibody therapy for familial amyloidotic polyneuropathy. Amyloid 19, 45-46
21. Phay, M., Blinder, V., Macy, S., Greene, M. J., Wooliver, D. C., Liu, W., Planas, A., Walsh, D. M., Connors, L. H., Primmer, S. R., Planque, S. A., Paul, S., and O'Nuallain, B. (2014) Transthyretin aggregate-specific antibodies recognize cryptic epitopes on patient-derived amyloid fibrils. Rejuvenation Res. 17, 97-104
22. Wisniewski, T., and Goñi, F. (2015) Immunotherapeutic approaches for Alzheimer's disease. Neuron 85, 1162-1176
23. Lannfelt, L., Relkin, N. R., and Siemers, E. R. (2014) Amyloid-β-directed immunotherapy for Alzheimer's disease. J. Intern. Med. 275, 284-295
24. Arsequell, G., and Planas, A. (2012) Methods to evaluate the inhibition of TTR fibrillogenesis induced by small ligands. Curr. Med. Chem. 19, 2343-2355
25. Matsubara, K., Mizuguchi, M., and Kawano, K. (2003) Expression of a synthetic gene encoding human transthyretin in Escherichia coli. Protein Expr. Purif. 30, 55-61
26. Episkopou, V., Maeda, S., Nishiguchi, S., Shimada, K., Gaitanaris, G. A., Gottesman, M. E., and Robertson, E. J. (1993) Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc. Natl. Acad. Sci. U.S.A. 90, 2375-2379
27. Köhler, G., and Milstein, C. (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495-497
28. Yonemura, H., Imamura, T., Soejima, K., Nakahara, Y., Morikawa, W., Ushio, Y., Kamachi, Y., Nakatake, H., Sugawara, K., Nakagaki, T., and Nozaki, C. (2004) Preparation of recombinant α-thrombin: high-level expression of recombinant human prethrombin-2 and its activation by recombinant ecarin. J. Biochem. 135, 577-582
29. Foote, J., and Winter, G. (1992) Antibody framework residues affecting the conformation of the hypervariable loops. J. Mol. Biol. 224, 487-499
30. Winter, G., and Milstein, C. (1991) Man-made antibodies. Nature 349, 293-299
31. Khurana, R., Coleman, C., Ionescu-Zanetti, C., Carter, S. A., Krishna, V., Grover, R. K., Roy, R., and Singh, S. (2005) Mechanism of thioflavin T binding to amyloid fibrils. J. Struct. Biol. 151, 229-238
32. Haruta, M., Tomita, Y., Yuno, A., Matsumura, K., Ikeda, T., Takamatsu, K., Haga, E., Koba, C., Nishimura, Y., and Senju, S. (2013) TAP-deficient human iPS cell-derived myeloid cell lines as unlimited cell source for dendritic cell-like antigen-presenting cells. Gene Ther. 20, 504-513
33. Ueda, M., Ando, Y., Nakamura, M., Yamashita, T., Himeno, S., Kim, J., Sun, X., Saito, S., Tateishi, T., Bergström, J., and Uchino, M. (2006) FK506 inhibits murine AA amyloidosis: possible involvement of T cells in amyloidogenesis. J. Rheumatol. 33, 2260-2270